Editorial 2017 by Thompson, A et al.
  
Editorial 2017 
 
Alan Thompson,  Jack Antel,  William (Bill) Carroll,  Jeroen Geurts 
 
 
With each year, we see new developments across research and therapeutics in multiple sclerosis 
with improved understanding of this challenging condition and exciting new advances. These are 
well reflected in the submissions to MSJ which have maintained their number and improved in 
quality, year on year. Our ongoing partnership with the TRIMS insures that we stay at the forefront 
of the field. We have continued all our recent initiatives and have introduced others. The most 
notable is a new series of short pieces entitled Insights into …. These will provide straightforward 
insights into areas which many of us find challenging - we are beginning in this issue with the first of 
six short pieces on statistics.  Other planned topics for 2017 include  microbiome research and 
epigenomics.  
It has been very encouraging to see how our open access journal, MSJ-ETC, is evolving - we have 
now had over 60 submissions of which 34 have been published. We are embarking on themed issues 
looking at MS in different geographic areas of the world, commencing with Latin America with guest 
editors Jorge Correale and Daniel Onteneda.  
Another exciting and successful development has been the appointment of a social media editor, 
Wallace Brownlee, who hails from New Zealand and is based in London. He has made great strides in 
bringing us into the 21st Century. In all seriousness, since we launched our Twitter account 
(@msj_research) in September we have seen very lively engagement and can now boast 234 very 
active followers. To engage with us use hash tag #msj  
Underpinning the journal’s success is our editorial board and we have recently invited 12 new 
members to join us - covering a broad range of interests and expertise. We are very grateful to those 
that have stepped down.  They have made a major contribution to MSJ and of course we hope they 
will continue to support the journal, both submitting and reviewing articles.  
The editorial board meeting in London was as lively as ever with much discussion covering all the 
recent developments and many new ideas. We had a particularly useful discussion on the subject of 
themed issues after the success of Ruth-Anne Marrie’s popular issue on the important topic of co-
morbidities. A number of potential topics covering bio-medical, disease outcome, and clinical care 
challenges were suggested for the coming year.  
Finally, just as we are writing this piece, the long-awaited and much improved  new website has 
arrived - it has a very fresh, modern look to it and even more importantly, it is very easy to access 
information about the journal, the editors and the editorial board. 
So, it has been a busy, productive and exciting year and we anticipate that this pattern will continue. 
We are keen to consider new initiatives and to be as interactive and responsive as possible. If any of 
you, our readers, have suggestions to make please do so - there is no shortage of avenues of 
communication and to the many hundreds of you who take the time and make the effort to provide 
instructive and helpful reviews - many thanks. Thanks also to the SAGE team, led by Jennie who 
respond to our many suggestions with energy and enthusiasm and to our local support who keep us 
on our toes and on time! 
 We hope you had a relaxing and enjoyable Holiday season and here’s to a healthy, successful and, 
above all, peaceful 2017. 
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